Sequoia Financial Advisors LLC Acquires 15,257 Shares of Waters Corporation (NYSE:WAT)

Sequoia Financial Advisors LLC grew its holdings in shares of Waters Corporation (NYSE:WAT - Free Report) by 1,055.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,702 shares of the medical instruments supplier's stock after buying an additional 15,257 shares during the period. Sequoia Financial Advisors LLC's holdings in Waters were worth $6,156,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Brighton Jones LLC lifted its holdings in shares of Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier's stock worth $471,000 after purchasing an additional 673 shares in the last quarter. New York Life Investment Management LLC lifted its holdings in shares of Waters by 1.2% in the 4th quarter. New York Life Investment Management LLC now owns 8,910 shares of the medical instruments supplier's stock worth $3,305,000 after purchasing an additional 108 shares in the last quarter. Mn Services Vermogensbeheer B.V. lifted its holdings in shares of Waters by 1.8% in the 4th quarter. Mn Services Vermogensbeheer B.V. now owns 23,033 shares of the medical instruments supplier's stock worth $8,545,000 after purchasing an additional 400 shares in the last quarter. Proficio Capital Partners LLC bought a new position in shares of Waters in the 4th quarter worth $42,114,000. Finally, Versor Investments LP bought a new position in shares of Waters in the 4th quarter worth $557,000. 94.01% of the stock is currently owned by institutional investors.

Waters Trading Down 0.7%

Shares of Waters stock opened at $352.28 on Friday. The stock has a fifty day moving average price of $347.11 and a 200-day moving average price of $365.16. Waters Corporation has a 1 year low of $279.24 and a 1 year high of $423.56. The firm has a market cap of $20.96 billion, a PE ratio of 31.97, a P/E/G ratio of 3.58 and a beta of 1.11. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.81 and a quick ratio of 1.28.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.03. Waters had a return on equity of 41.70% and a net margin of 22.02%. The company had revenue of $661.71 million during the quarter, compared to analyst estimates of $655.50 million. During the same quarter last year, the firm posted $2.21 EPS. The firm's revenue for the quarter was up 3.9% on a year-over-year basis. Equities research analysts anticipate that Waters Corporation will post 12.86 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Sanford C. Bernstein set a $400.00 target price on Waters and gave the stock an "outperform" rating in a report on Wednesday, April 16th. JPMorgan Chase & Co. increased their price target on Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a research report on Thursday, March 6th. Barclays lowered their price target on Waters from $400.00 to $350.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Robert W. Baird increased their price target on Waters from $355.00 to $374.00 and gave the company an "outperform" rating in a research report on Wednesday, May 7th. Finally, Wall Street Zen lowered Waters from a "buy" rating to a "hold" rating in a research report on Saturday, June 7th. Ten investment analysts have rated the stock with a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Waters presently has a consensus rating of "Moderate Buy" and an average price target of $388.00.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.